UMediC Group Berhad (0256) - Net Assets

Latest as of October 2025: RM83.20 Million MYR ≈ $20.89 Million USD

Based on the latest financial reports, UMediC Group Berhad (0256) has net assets worth RM83.20 Million MYR (≈ $20.89 Million USD) as of October 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (RM94.93 Million ≈ $23.83 Million USD) and total liabilities (RM11.72 Million ≈ $2.94 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check UMediC Group Berhad liquidity resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	RM83.20 Million
% of Total Assets	87.65%
Annual Growth Rate	65.11%
5-Year Change	416.9%
10-Year Change	N/A
Growth Volatility	89.01

UMediC Group Berhad - Net Assets Trend (2020–2025)

This chart illustrates how UMediC Group Berhad's net assets have evolved over time, based on quarterly financial data. Also explore UMediC Group Berhad assets under control for the complete picture of this company's asset base.

Annual Net Assets for UMediC Group Berhad (2020–2025)

The table below shows the annual net assets of UMediC Group Berhad from 2020 to 2025. For live valuation and market cap data, see market cap of UMediC Group Berhad.

Year	Net Assets	Change
2025-07-31	RM81.35 Million ≈ $20.42 Million	+11.79%
2024-07-31	RM72.77 Million ≈ $18.27 Million	+14.65%
2023-07-31	RM63.48 Million ≈ $15.94 Million	+20.50%
2022-07-31	RM52.68 Million ≈ $13.23 Million	+234.71%
2021-07-31	RM15.74 Million ≈ $3.95 Million	+137.32%
2020-07-31	RM6.63 Million ≈ $1.67 Million	--

Equity Component Analysis

This analysis shows how different components contribute to UMediC Group Berhad's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 1038.3% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (July 2025)

Component	Amount	Percentage
Retained Earnings	RM42.62 Million	53.20%
Other Components	RM37.50 Million	46.80%
Total Equity	RM80.12 Million	100.00%

UMediC Group Berhad Competitors by Market Cap

The table below lists competitors of UMediC Group Berhad ranked by their market capitalization.

Company	Market Cap
Locksley Resources Ltd AU:LKY	$28.64 Million
JSW Pacific TWO:5251	$28.64 Million
Venus Metals Corporation Ltd AU:VMC	$28.66 Million
A2Z Infra Engineering Limited NSE:A2ZINFRA	$28.67 Million
RMG Acquisition Corp. III NASDAQ:RMGCF	$28.63 Million
Taya Inv-L TA:TAYA	$28.63 Million
Barinthus Biotherapeutics plc NASDAQ:BRNS	$28.62 Million
Goldenstone Acquisition Ltd NASDAQ:GDST	$28.62 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in UMediC Group Berhad's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 71,984,674 to 80,118,000, a change of 8,133,326 (11.3%).
Net income of 8,133,578 contributed positively to equity growth.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	RM8.13 Million	+10.15%
Other Changes	RM-252.00	-0.0%
Total Change	RM-	11.30%

Book Value vs Market Value Analysis

This analysis compares UMediC Group Berhad's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.42x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 17.20x to 1.42x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2020-07-31	RM0.02	RM0.31	x
2021-07-31	RM0.04	RM0.31	x
2022-07-31	RM0.14	RM0.31	x
2023-07-31	RM0.17	RM0.31	x
2024-07-31	RM0.19	RM0.31	x
2025-07-31	RM0.21	RM0.31	x

Capital Efficiency Dashboard

This dashboard shows how efficiently UMediC Group Berhad utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 10.15%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 16.75%
• Asset Turnover: 0.53x
• Equity Multiplier: 1.14x
Recent ROE (10.15%) is below the historical average (20.00%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2020	36.47%	10.22%	0.79x	4.51x	RM1.76 Million
2021	32.32%	14.91%	0.68x	3.17x	RM3.51 Million
2022	12.20%	12.67%	0.74x	1.31x	RM1.16 Million
2023	16.38%	22.70%	0.62x	1.16x	RM4.02 Million
2024	12.49%	16.48%	0.66x	1.15x	RM1.79 Million
2025	10.15%	16.75%	0.53x	1.14x	RM121.78K

Industry Comparison

This section compares UMediC Group Berhad's net assets metrics with peer companies in the Medical Devices industry.

No peer company data available for comparison.

About UMediC Group Berhad

KLSE:0256 Malaysia Medical Devices

Market Cap

$28.63 Million

RM114.04 Million MYR

Market Cap Rank

#23959 Global

#599 in Malaysia

Share Price

RM0.31

Change (1 day)

+0.00%

52-Week Range

RM0.28 - RM0.47

All Time High

RM0.89